Published in Neoplasia on December 01, 2013
The anti-diabetic drug metformin protects against chemotherapy-induced peripheral neuropathy in a mouse model. PLoS One (2014) 1.13
Recent advances in the use of metformin: can treating diabetes prevent breast cancer? Biomed Res Int (2015) 0.87
Minireview: hey U(PS): metabolic and proteolytic homeostasis linked via AMPK and the ubiquitin proteasome system. Mol Endocrinol (2014) 0.83
Cancer subclonal genetic architecture as a key to personalized medicine. Neoplasia (2013) 0.78
Changes in [18F]Fluoro-2-deoxy-D-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signalling. J Cancer Res Clin Oncol (2015) 0.77
The Role of BCA2 in the Endocytic Trafficking of EGFR and Significance as a Prognostic Biomarker in Cancer. J Cancer (2016) 0.75
Expression of transmembrane protein 26 (TMEM26) in breast cancer and its association with drug response. Oncotarget (2016) 0.75
Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet (1998) 22.64
Standards of medical care in diabetes--2009. Diabetes Care (2009) 15.78
Metformin and reduced risk of cancer in diabetic patients. BMJ (2005) 13.04
Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol (2003) 12.91
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer (2009) 8.43
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J (2000) 7.77
Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem (1996) 7.23
5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem (1995) 7.12
Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res (Phila) (2010) 4.36
AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature (2012) 3.85
Tamoxifen: a most unlikely pioneering medicine. Nat Rev Drug Discov (2003) 3.07
Investigating metformin for cancer prevention and treatment: the end of the beginning. Cancer Discov (2012) 3.02
Control of AMPK-related kinases by USP9X and atypical Lys(29)/Lys(33)-linked polyubiquitin chains. Biochem J (2008) 2.67
Insulin-lowering effects of metformin in women with early breast cancer. Clin Breast Cancer (2008) 2.53
The active form of the metabolic sensor: AMP-activated protein kinase (AMPK) directly binds the mitotic apparatus and travels from centrosomes to the spindle midzone during mitosis and cytokinesis. Cell Cycle (2009) 2.03
Metformin in cancer: translational challenges. J Mol Endocrinol (2012) 1.94
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial. Breast Cancer Res Treat (2011) 1.90
Location and function of three sites phosphorylated on rat acetyl-CoA carboxylase by the AMP-activated protein kinase. Eur J Biochem (1990) 1.83
AMP-activated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cellular metabolism. Cell Mol Life Sci (2008) 1.77
The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase. Biochim Biophys Acta (1989) 1.76
AMP-activated protein kinase: new regulation, new roles? Biochem J (2012) 1.75
Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells. Breast Cancer Res Treat (2010) 1.67
Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model. Breast Cancer Res Treat (2008) 1.64
The ubiquitin-mediated proteolytic pathway: mode of action and clinical implications. J Cell Biochem Suppl (2000) 1.61
AMP-activated protein kinase promotes human prostate cancer cell growth and survival. Mol Cancer Ther (2009) 1.48
Downregulation of AMP-activated protein kinase by Cidea-mediated ubiquitination and degradation in brown adipose tissue. EMBO J (2008) 1.33
Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy. Mol Cancer (2007) 1.31
BCA2/Rabring7 promotes tetherin-dependent HIV-1 restriction. PLoS Pathog (2009) 1.24
Autoubiquitination of BCA2 RING E3 ligase regulates its own stability and affects cell migration. Mol Cancer Res (2008) 1.21
A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer. Cancer Res (2005) 1.21
Novel RING E3 ubiquitin ligases in breast cancer. Neoplasia (2006) 1.14
The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention. Curr Protein Pept Sci (2010) 1.08
AMPK exerts dual regulatory effects on the PI3K pathway. J Mol Signal (2010) 1.05
From bortezomib to other inhibitors of the proteasome and beyond. Curr Pharm Des (2013) 1.04
AMPK and Akt determine apoptotic cell death following perturbations of one-carbon metabolism by regulating ER stress in acute lymphoblastic leukemia. Mol Cancer Ther (2011) 1.03
AMPK activation by oncogenesis is required to maintain cancer cell proliferation in astrocytic tumors. Cancer Res (2013) 1.03
HER2-targeted therapy in breast cancer: a systematic review of neoadjuvant trials. Cancer Treat Rev (2013) 1.01
Therapeutic anti-cancer targets upstream of the proteasome. Cancer Treat Rev (2003) 0.97
AMPK-induced activation of Akt by AICAR is mediated by IGF-1R dependent and independent mechanisms in acute lymphoblastic leukemia. J Mol Signal (2010) 0.96
Cellular responses to the metal-binding properties of metformin. Diabetes (2012) 0.96
Regulation of AMPK by the ubiquitin proteasome system. Am J Pathol (2010) 0.92
Effects of partner proteins on BCA2 RING ligase activity. BMC Cancer (2012) 0.89
Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study. Clin Breast Cancer (2012) 0.87
Role of the BCA2 ubiquitin E3 ligase in hormone responsive breast cancer. Open Cancer J (2010) 0.85
Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor. Breast Cancer Res Treat (2012) 0.82